253 related articles for article (PubMed ID: 32633635)
41. Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
Liau WS; Tan SH; Ngoc PCT; Wang CQ; Tergaonkar V; Feng H; Gong Z; Osato M; Look AT; Sanda T
Leukemia; 2017 Aug; 31(8):1798-1807. PubMed ID: 28028313
[TBL] [Abstract][Full Text] [Related]
42. ToTAL1y degraded - rapid dTAG proteolysis of TAL1 in T-cell acute lymphoblastic leukemia.
Costa JR; Mansour MR
Haematologica; 2024 May; 109(5):1325-1327. PubMed ID: 38105739
[No Abstract] [Full Text] [Related]
43. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.
Sanda T; Leong WZ
Exp Hematol; 2017 Sep; 53():7-15. PubMed ID: 28652130
[TBL] [Abstract][Full Text] [Related]
44. SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome.
Laukkanen S; Oksa L; Nikkilä A; Lahnalampi M; Parikka M; Seki M; Takita J; Degerman S; de Bock CE; Heinäniemi M; Lohi O
Leuk Lymphoma; 2020 Dec; 61(13):3089-3100. PubMed ID: 32835548
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-374b Suppresses Proliferation and Promotes Apoptosis in T-cell Lymphoblastic Lymphoma by Repressing AKT1 and Wnt-16.
Qian D; Chen K; Deng H; Rao H; Huang H; Liao Y; Sun X; Lu S; Yuan Z; Xie D; Cai Q
Clin Cancer Res; 2015 Nov; 21(21):4881-91. PubMed ID: 26100275
[TBL] [Abstract][Full Text] [Related]
46. [Clinical features of 19 patients with SIL-TAL1-positive T-cell acute lymphoblastic leukemia].
Wang LJ; Chen Y; Xiang M; Yang XF; Chen SN
Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):132-136. PubMed ID: 36948867
[No Abstract] [Full Text] [Related]
47. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.
Palomero T; Odom DT; O'Neil J; Ferrando AA; Margolin A; Neuberg DS; Winter SS; Larson RS; Li W; Liu XS; Young RA; Look AT
Blood; 2006 Aug; 108(3):986-92. PubMed ID: 16621969
[TBL] [Abstract][Full Text] [Related]
48. CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia.
Cardoso BA; Duque M; Gírio A; Fragoso R; Oliveira ML; Allen JR; Martins LR; Correia NC; Silveira AB; Veloso A; Kimura S; Demoen L; Matthijssens F; Jeha S; Cheng C; Pui CH; Grosso AR; Neto JL; De Almeida SF; Van Vlieberghe P; Mullighan CG; Yunes JA; Langenau DM; Pflumio F; Barata JT
Haematologica; 2024 Jun; 109(6):1713-1725. PubMed ID: 38058200
[TBL] [Abstract][Full Text] [Related]
49. miR-145-5p Acts as a Novel Tumor Suppressor in Hepatocellular Carcinoma Through Targeting RAB18.
Wang B; Dong W; Li X
Technol Cancer Res Treat; 2019 Jan; 18():1533033819850189. PubMed ID: 31106707
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA profiling reveals aberrant microRNA expression in adult ETP-ALL and functional studies implicate a role for miR-222 in acute leukemia.
Coskun E; Neumann M; Schlee C; Liebertz F; Heesch S; Goekbuget N; Hoelzer D; Baldus CD
Leuk Res; 2013 Jun; 37(6):647-56. PubMed ID: 23522449
[TBL] [Abstract][Full Text] [Related]
51. ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer.
Thoms JA; Birger Y; Foster S; Knezevic K; Kirschenbaum Y; Chandrakanthan V; Jonquieres G; Spensberger D; Wong JW; Oram SH; Kinston SJ; Groner Y; Lock R; MacKenzie KL; Göttgens B; Izraeli S; Pimanda JE
Blood; 2011 Jun; 117(26):7079-89. PubMed ID: 21536859
[TBL] [Abstract][Full Text] [Related]
52. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study.
Bash RO; Hall S; Timmons CF; Crist WM; Amylon M; Smith RG; Baer R
Blood; 1995 Jul; 86(2):666-76. PubMed ID: 7605997
[TBL] [Abstract][Full Text] [Related]
53. miR-590 promotes cell proliferation and invasion in T-cell acute lymphoblastic leukaemia by inhibiting RB1.
Miao MH; Ji XQ; Zhang H; Xu J; Zhu H; Shao XJ
Oncotarget; 2016 Jun; 7(26):39527-39534. PubMed ID: 27036041
[TBL] [Abstract][Full Text] [Related]
54. microRNA-452 exerts growth-suppressive activity against T-cell acute lymphoblastic leukemia.
Wang H; Guo Q; Zhu G; Zhu S; Yang P; Zhang M
J Investig Med; 2018 Apr; 66(4):773-779. PubMed ID: 29326345
[TBL] [Abstract][Full Text] [Related]
55. hsa-miR-20b-5p and hsa-miR-363-3p Affect Expression of
Drobna M; Szarzyńska B; Jaksik R; Sędek Ł; Kuchmiy A; Taghon T; Van Vlierberghe P; Szczepański T; Witt M; Dawidowska M
Cells; 2020 May; 9(5):. PubMed ID: 32380791
[TBL] [Abstract][Full Text] [Related]
56. The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia.
Furness CL; Mansur MB; Weston VJ; Ermini L; van Delft FW; Jenkinson S; Gale R; Harrison CJ; Pombo-de-Oliveira MS; Sanchez-Martin M; Ferrando AA; Kearns P; Titley I; Ford AM; Potter NE; Greaves M
Leukemia; 2018 Sep; 32(9):1984-1993. PubMed ID: 29556024
[TBL] [Abstract][Full Text] [Related]
57. Oncorequisite role of an aldehyde dehydrogenase in the pathogenesis of T-cell acute lymphoblastic leukemia.
Zhang C; Amanda S; Wang C; King Tan T; Zulfaqar Ali M; Zhong Leong W; Moy Ng L; Kitajima S; Li Z; Eng Juh Yeoh A; Hao Tan S; Sanda T
Haematologica; 2021 Jun; 106(6):1545-1558. PubMed ID: 32414855
[TBL] [Abstract][Full Text] [Related]
58. TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells.
Cardoso BA; de Almeida SF; Laranjeira AB; Carmo-Fonseca M; Yunes JA; Coffer PJ; Barata JT
Leukemia; 2011 Oct; 25(10):1578-86. PubMed ID: 21647153
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-183 promotes cell proliferation via regulating programmed cell death 6 in pediatric acute myeloid leukemia.
Wang X; Zuo D; Yuan Y; Yang X; Hong Z; Zhang R
J Cancer Res Clin Oncol; 2017 Jan; 143(1):169-180. PubMed ID: 27738758
[TBL] [Abstract][Full Text] [Related]
60. Repressed BMP signaling reactivates NKL homeobox gene MSX1 in a T-ALL subset.
Nagel S; Ehrentraut S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Leuk Lymphoma; 2015 Feb; 56(2):480-91. PubMed ID: 24844359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]